Skip to main content
Erschienen in: Acta Neuropathologica 3/2005

01.09.2005 | Regular Paper

Individual and regional variations of phospho-tau species in progressive supranuclear palsy

verfasst von: Berta Puig, María Jesus Rey, Isidre Ferrer

Erschienen in: Acta Neuropathologica | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to learn about possible variations in phospho-tau profiles in terms of case-to-case differences, regional modifications and diversification of tau phosphorylation sites in five PSP cases with moderate to severe frontosubcortical dysfunction. Gel electrophoresis of sarkosyl-insoluble fractions and Western blotting with five anti-tau phospho-specific antibodies directed to phosphorylation sites Thr181, Ser202, Ser214, Ser396 and Ser422 were used to study four brain regions including frontal cortex, area 8, subcortical white matter of the frontal lobe, caudate/putamen: striatum, and basis pontis: pons. Although two bands of 66 and 62 kDa were observed in almost every region in each case, the intensity of the bands depends on the anti-tau phospho-specific antibody. More importantly, bands of 72, 50/55 and 37 kDa were commonly found in PSP brains, whereas other bands of about 60, 42, 33 and 29 kDa were irregularly observed. The pattern of bands differed slightly from one case to another and from one region to another. Moreover, the phospho-tau profile differed depending on the anti-tau phospho-specific antibody used. These data suggest that several species of tau are variably phosphorylated at a given time in a given region (and probably in a given cell), and that tau aggregates are composed of several phosphorylated truncated or cleaved tau molecules, in addition to phosphorylated complete tau isoforms.
Literatur
1.
Zurück zum Zitat Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31:10626–10633PubMed Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31:10626–10633PubMed
2.
Zurück zum Zitat Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL (2001) Distinct isoforms of tau aggregate in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101:167–173PubMed Arai T, Ikeda K, Akiyama H, Shikamoto Y, Tsuchiya K, Yagishita S, Beach T, Rogers J, Schwab C, McGeer PL (2001) Distinct isoforms of tau aggregate in neurons and glial cells in brains of patients with Pick’s disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 101:167–173PubMed
3.
Zurück zum Zitat Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E (2003) Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 105:489–498PubMed Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E (2003) Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer’s disease, Pick’s disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 105:489–498PubMed
4.
Zurück zum Zitat Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, Ishiguro K, Iritani S, Tsuchiya K, Iseki E, Yagishita S, Oda T, Mochizuki A (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72–79CrossRefPubMed Arai T, Ikeda K, Akiyama H, Nonaka T, Hasegawa M, Ishiguro K, Iritani S, Tsuchiya K, Iseki E, Yagishita S, Oda T, Mochizuki A (2004) Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol 55:72–79CrossRefPubMed
5.
Zurück zum Zitat Arima K, Nakamura M, Sunohara N, Ogawa M, Anno M, Izumiyama Y, Hirai S, Ikeda K (1997) Ultrastructural characterization of the tau-immunoreactive tubules in oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 93:558–556PubMed Arima K, Nakamura M, Sunohara N, Ogawa M, Anno M, Izumiyama Y, Hirai S, Ikeda K (1997) Ultrastructural characterization of the tau-immunoreactive tubules in oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy. Acta Neuropathol 93:558–556PubMed
6.
Zurück zum Zitat Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361–384PubMed Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361–384PubMed
7.
Zurück zum Zitat Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130CrossRefPubMed Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130CrossRefPubMed
8.
Zurück zum Zitat Bugiani O, Mancardi GL, Brusa A, Ederli A (1979) The fine structure of subcortical neurofibrilllary tangles in progressive supranuclear palsy. Acta Neuropathol 45:147–152PubMed Bugiani O, Mancardi GL, Brusa A, Ederli A (1979) The fine structure of subcortical neurofibrilllary tangles in progressive supranuclear palsy. Acta Neuropathol 45:147–152PubMed
9.
Zurück zum Zitat Csokova N, Skrabbana R, Liebig HD, Mederlyova A, Kontsek P, Novak M (2004) Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Prot Exp Purif 35:366–372 Csokova N, Skrabbana R, Liebig HD, Mederlyova A, Kontsek P, Novak M (2004) Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Prot Exp Purif 35:366–372
10.
Zurück zum Zitat Delacourte A, Buée L (2000) Tau pathology: a marker of neurodegenerative disorders. Curr Opin Neurol 13:371–376PubMed Delacourte A, Buée L (2000) Tau pathology: a marker of neurodegenerative disorders. Curr Opin Neurol 13:371–376PubMed
11.
Zurück zum Zitat De Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, Bandopadhyay R, Utton M, Strand C, Jowett N, Khan N, Anderton B, Wood N, Holton J, Revesz T, Lees A (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three of four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288–302CrossRefPubMed De Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, Bandopadhyay R, Utton M, Strand C, Jowett N, Khan N, Anderton B, Wood N, Holton J, Revesz T, Lees A (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three of four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288–302CrossRefPubMed
12.
Zurück zum Zitat Dickson DW (2001) Progressive supranuclear palsy and corticobasal degeneration. In: Hof PR, Mobbs CV (eds) Functional neurobiology of aging. Academic Press, New York, pp 155–171 Dickson DW (2001) Progressive supranuclear palsy and corticobasal degeneration. In: Hof PR, Mobbs CV (eds) Functional neurobiology of aging. Academic Press, New York, pp 155–171
13.
Zurück zum Zitat Ferrer I, Gómez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J (2005) Current advances on different kinases involved in tau phosphorylation and implications in Alzheimer’s disease and tauopathies. Curr Alzheimer Res 2:3–18CrossRef Ferrer I, Gómez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J (2005) Current advances on different kinases involved in tau phosphorylation and implications in Alzheimer’s disease and tauopathies. Curr Alzheimer Res 2:3–18CrossRef
14.
Zurück zum Zitat Flament S, Delacourte A, Verny M, Hauw HH, Javoy-Agid F (1991) Abnormal tau proteins in progressive supranuclear palsy. Acta Neuropathol 81:591–596CrossRefPubMed Flament S, Delacourte A, Verny M, Hauw HH, Javoy-Agid F (1991) Abnormal tau proteins in progressive supranuclear palsy. Acta Neuropathol 81:591–596CrossRefPubMed
15.
Zurück zum Zitat Gearing M, Olson DA, Watts RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44:1015–1024PubMed Gearing M, Olson DA, Watts RL, Mirra SS (1994) Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 44:1015–1024PubMed
16.
Zurück zum Zitat Gibb GM, De Silva R, Revesz T, Lees AJ, Anderton BH, Hanger DP (2004) Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. Mol Brain Res 121:95–101PubMed Gibb GM, De Silva R, Revesz T, Lees AJ, Anderton BH, Hanger DP (2004) Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. Mol Brain Res 121:95–101PubMed
17.
Zurück zum Zitat Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–526CrossRefPubMed Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–526CrossRefPubMed
18.
Zurück zum Zitat Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau-proteins of Alzheimer paired helical filaments—abnormal phosphorylaiton of all six brain isoforms. Neuron 8:159–168CrossRefPubMed Goedert M, Spillantini MG, Cairns NJ, Crowther RA (1992) Tau-proteins of Alzheimer paired helical filaments—abnormal phosphorylaiton of all six brain isoforms. Neuron 8:159–168CrossRefPubMed
19.
Zurück zum Zitat Goedert M, Spillantini MG, Jakes R, Crowther FA, Vanmechelen E, Probst A, Gostz J, Burki K, Cohen P (1995) Molecular dissection of the paired helical filament. Neurobiol Aging 16:325–334PubMed Goedert M, Spillantini MG, Jakes R, Crowther FA, Vanmechelen E, Probst A, Gostz J, Burki K, Cohen P (1995) Molecular dissection of the paired helical filament. Neurobiol Aging 16:325–334PubMed
20.
Zurück zum Zitat Goedert M, Spillantini MG, Davis SW (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619–632PubMed Goedert M, Spillantini MG, Davis SW (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619–632PubMed
21.
Zurück zum Zitat Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S (1995) Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 21:319–326PubMed Hanihara T, Amano N, Takahashi T, Nagatomo H, Yagashita S (1995) Distribution of tangles and threads in the cerebral cortex in progressive supranuclear palsy. Neuropathol Appl Neurobiol 21:319–326PubMed
22.
Zurück zum Zitat Hauw JJ, Agid Y (2003) Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 103–114 Hauw JJ, Agid Y (2003) Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski disease. In: Dickson D (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 103–114
23.
Zurück zum Zitat Hauw JJ, Verny M, Ruberg M, Duyckaerts C (1998) The neuropathology of progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski disease. In: Markesberry W (ed) The neuropathology of dementing disorders. Edward Arnold, London, pp 193–218 Hauw JJ, Verny M, Ruberg M, Duyckaerts C (1998) The neuropathology of progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski disease. In: Markesberry W (ed) The neuropathology of dementing disorders. Edward Arnold, London, pp 193–218
24.
Zurück zum Zitat Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T (1994) Argyrophilic thread-like structures in corticobasal degeneration and supranuclear palsy. Neurosci Lett 174:157–159PubMed Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T (1994) Argyrophilic thread-like structures in corticobasal degeneration and supranuclear palsy. Neurosci Lett 174:157–159PubMed
25.
Zurück zum Zitat Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. Brain Pathol 9:663–679PubMed Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick’s disease. Brain Pathol 9:663–679PubMed
26.
Zurück zum Zitat Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu WK (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145:1496–1508PubMed Ksiezak-Reding H, Morgan K, Mattiace LA, Davies P, Liu WK (1994) Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 145:1496–1508PubMed
27.
Zurück zum Zitat Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159CrossRefPubMed Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159CrossRefPubMed
28.
Zurück zum Zitat Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Halett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Halett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed
29.
Zurück zum Zitat Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabatton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105PubMed Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabatton M, Jellinger K, Anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97–105PubMed
30.
Zurück zum Zitat Liu WK, Le TV, Adamson J, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW (2001) Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 50:494–502PubMed Liu WK, Le TV, Adamson J, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW (2001) Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 50:494–502PubMed
31.
Zurück zum Zitat Luo MH, Tse SW, Memmott J, Andreadis A (2004) Novel isoforms of tau that lack the microtubule-binding domain. J Neurochem 90:340–351PubMed Luo MH, Tse SW, Memmott J, Andreadis A (2004) Novel isoforms of tau that lack the microtubule-binding domain. J Neurochem 90:340–351PubMed
32.
Zurück zum Zitat Maillot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L (1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 443:201–204CrossRef Maillot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L (1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 443:201–204CrossRef
33.
Zurück zum Zitat Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T (2002) Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125:969–975PubMed Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T (2002) Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain 125:969–975PubMed
34.
Zurück zum Zitat Nishimura M, Namba Y, Ikeda K, Oda M (1992) Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett 143:35–38PubMed Nishimura M, Namba Y, Ikeda K, Oda M (1992) Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett 143:35–38PubMed
35.
Zurück zum Zitat Roy S, Datta CK, Hirano A, Ghatak NR, Zimmerman HM (1974) Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Acta Neuropathol 29:175–179PubMed Roy S, Datta CK, Hirano A, Ghatak NR, Zimmerman HM (1974) Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Acta Neuropathol 29:175–179PubMed
36.
Zurück zum Zitat Scaravilli T, Tolosa E, Ferrer I (2005) Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov Dis (in press) Scaravilli T, Tolosa E, Ferrer I (2005) Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov Dis (in press)
37.
Zurück zum Zitat Sergeant N, Wattez A, Delacourte A (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively “exon 10” isoforms. J Neurochem 72:1243–1249CrossRefPubMed Sergeant N, Wattez A, Delacourte A (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively “exon 10” isoforms. J Neurochem 72:1243–1249CrossRefPubMed
38.
Zurück zum Zitat Steele J, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogenous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359PubMed Steele J, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogenous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333–359PubMed
39.
Zurück zum Zitat Takahashi M, Weidenheim KM, Dickson DW, Ksiezak-Reding H (2002) Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. J Neuropathol Exp Neurol 61:33–45PubMed Takahashi M, Weidenheim KM, Dickson DW, Ksiezak-Reding H (2002) Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy. J Neuropathol Exp Neurol 61:33–45PubMed
40.
Zurück zum Zitat Téllez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 29:324–327PubMed Téllez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 29:324–327PubMed
41.
Zurück zum Zitat Togo T, Dickson DW (2002) Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 104:398–402PubMed Togo T, Dickson DW (2002) Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol 104:398–402PubMed
42.
Zurück zum Zitat Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A (1994) Biochemical mapping of neurofibrillar degeneration in one case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 87:572–577CrossRefPubMed Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A (1994) Biochemical mapping of neurofibrillar degeneration in one case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol 87:572–577CrossRefPubMed
43.
Zurück zum Zitat Verny M, Duyckaerts C, Agid Y, Hauw JJ (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 119:1123–1136PubMed Verny M, Duyckaerts C, Agid Y, Hauw JJ (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 119:1123–1136PubMed
44.
Zurück zum Zitat Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y (1996) Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 91:427–431PubMed Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y (1996) Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol 91:427–431PubMed
45.
Zurück zum Zitat Wakabayashi K, Takahashi H (2004) Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24:79–86PubMed Wakabayashi K, Takahashi H (2004) Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration. Neuropathology 24:79–86PubMed
Metadaten
Titel
Individual and regional variations of phospho-tau species in progressive supranuclear palsy
verfasst von
Berta Puig
María Jesus Rey
Isidre Ferrer
Publikationsdatum
01.09.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 3/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1046-0

Weitere Artikel der Ausgabe 3/2005

Acta Neuropathologica 3/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.